Pushing the climate change agenda to protect the environment from bio-hazardous chemicals used in life science research and molecular diagnostic applications.

Azooka addressed India's PCR/RT PCR technology gap during COVID-19 by adopting ThermoFisher's solution. Azooka Eco-fluors use food-grade molecules, simplifying technology and eliminating biohazard risks. Their Molecular Transport Medium (MTM) preserves samples at room temperature for two weeks, offering cost-effective, pathogen-inactivating solutions, addressing accessibility challenges in India and other third-world countries.

Azooka's RNA WRAPR, a COVID-19 molecular transport medium, achieved rapid success, selling a million units in a year with no contamination reports, earning recognition and the Technology Start-up Award from the Technology Development Board. As the only private biotech company in India with a Genomics Manufacturing Unit, Azooka is featured in Bloomberg market reports. Their patented Eco-Fluors, offering a safe alternative for nucleic acid testing, have global recognition. The company's molecular transport mediums (MTM) now cater to diverse sample types, alleviating difficulties in obtaining collection kits for cancer and NIPT.

Over the next 3-5 years, Azooka, the exclusive safe genomics consumables vendor in Asia, aims to diversify its contributions to genomic and molecular diagnostics. Plans include consumables for mRNA research, cell stabilization for flow cytometry, expanding Eco-Fluors for DNA quantification, and global expansion through strategic licensing and regulatory approvals.